1. Home
  2. PCB vs CADL Comparison

PCB vs CADL Comparison

Compare PCB & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCB Bancorp

PCB

PCB Bancorp

HOLD

Current Price

$22.45

Market Cap

307.0M

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.11

Market Cap

339.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCB
CADL
Founded
2003
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.0M
339.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PCB
CADL
Price
$22.45
$6.11
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$24.50
$19.43
AVG Volume (30 Days)
20.6K
731.5K
Earning Date
01-27-2026
03-12-2026
Dividend Yield
3.64%
N/A
EPS Growth
43.50
N/A
EPS
2.41
N/A
Revenue
$107,743,000.00
N/A
Revenue This Year
$21.55
N/A
Revenue Next Year
$8.65
N/A
P/E Ratio
$9.12
N/A
Revenue Growth
13.61
N/A
52 Week Low
$16.00
$4.25
52 Week High
$24.04
$13.68

Technical Indicators

Market Signals
Indicator
PCB
CADL
Relative Strength Index (RSI) 48.53 54.72
Support Level $21.75 $5.91
Resistance Level $23.21 $6.62
Average True Range (ATR) 0.57 0.36
MACD 0.01 0.00
Stochastic Oscillator 34.74 55.25

Price Performance

Historical Comparison
PCB
CADL

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: